Receptor

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Lawyer hopes for class-action settlement in 2009: Cameron Inquiry expected to complete testimony on Oct. 24

Published October 7, 2008, 10:21 am, The Telegram

Lawyers will seek the court’s help next spring to help sort out how much breast cancer patients affected by hormone receptor testing errors should receive.

Discover News | Full Story


Many Receptor Models Used In Drug Design May Not Be Useful After All

Published October 7, 2008, 9:21 am, Science Daily

It may very well be that models used for the design of new drugs have to be regarded as impractical. Scientists have elucidated the structure of the adenosine A2A receptor, one of caffeine's main targets in the body and a key player in Parkinson's.

Discover News | Full Story


German cycling federation wants ban, fine for Stefan Schumacher

Published October 7, 2008, 7:54 am, Velo News

Double Tour de France stage winner Stefan Schumacher is facing a two-year ban and a fine after confirmation of a positive test for EPO (erythrpoietin), the German cycling federation (BDR) said Tuesday. Schumacher was the second rider on Monday to have been exposed as a drugs cheat, following the news that Italian Leonardo Piepoli, who won the race's 10th stage in the Pyrenees, also tested ...

Discover News | Full Story


Memos about lab problems weren't discussed among pathologists, inquiry told

Published October 7, 2008, 7:21 am, The Telegram

Pathologists weren’t talking about a series of memos red-flagging problems with hormone receptor testing in 2003, Dr.

Discover News | Full Story


Researchers Provide New Insights Into Common Alterations of ERG Oncogene in Prostate Cancer

Published October 7, 2008, 7:21 am, Newswise

In their continued quest to understand the functional role and clinical utility of ERG alterations in prostate cancer, CPDR researchers have now defined new features of ERG function and expression which will further enhance the potential of ERG as promising biomarker and therapeutic target for prostate cancer.

Discover News | Full Story


Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays

Published October 7, 2008, 7:15 am, PR Newswire via Yahoo! Finance

Caliper Life Sciences, Inc. and DiscoveRx, today announced the commercial availability of PathHunter eXpress Beta-Arrestin kits for use with Caliper's LabChip® 3000 and EZ Reader platforms to conduct cellular G protein-coupled receptor assays.

Discover News | Full Story


HairDX Announces Clinical Trial Of Genetically Tailored Therapy for Female Baldness

Published October 7, 2008, 7:08 am, Business Wire via Yahoo! Finance

IRVINE, Calif.----Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC , today announced that it has received institutional review board approval to begin a clinical trial of a genetically tailored therapy for female baldness .

Discover News | Full Story


3M Licenses Vaccine Adjuvants to Sanofi Pasteur

Published October 7, 2008, 7:00 am, Business Wire via Yahoo! Finance

ST. PAUL, Minn.----3M Drug Delivery Systems announces the signing of a non-exclusive license agreement with sanofi pasteur, the vaccines division of sanofi-aventis Group. Under the agreement, 3M will provide its patented toll-like receptor agonist compounds to sanofi pasteur for an undisclosed licensing fee, milestones and royalties for use as vaccine adjuvants.

Discover News | Full Story


Inventors Work to Advance Cancer Treatment Discovery Through New Start-Up Company

Published October 7, 2008, 6:24 am, Newswise

University of Virginia researchers Kevin R. Lynch and Timothy L. Macdonald have developed novel therapeutic compounds that could aid in the fight against cancer.

Discover News | Full Story


High Insulin-Like Hormone Linked to Risk of Prostate Cancer

Published October 7, 2008, 6:24 am, Bloomberg

Oct. 7 (Bloomberg) -- Higher than normal levels of an insulin-like hormone in the blood may signal an increased risk of prostate cancer, according to a new analysis of 12 studies.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a